Index of reports
> Cases with Hepatic Failure (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include hepatic failure. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug: Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug: Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug: Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug: Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Vfend
Administration route: Oral
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in
Reported by a physician from Germany on 2012-04-17
Patient:
Reactions: Hepatic Failure
Drug(s) suspected as cause:
Cancidas
Possible Cancidas side effects in female
Reported by a physician from Germany on 2011-12-21
Patient: female
Reactions: Hepatic Failure
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cancidas
|